Market Industry Reports (MIR) has published a new report titled “Breast Implant Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2030.” According to the report, the global breast implants market is estimated to account for over US$ 2.7 billion in 2019. It is anticipated to grow at a CAGR of 6.1% from 2019 to 2030.
Significant market growth can be attributed to the increasing number of breast augmentation procedures. Moreover, factors such as the rising prevalence of breast cancer, the launch of new products, and technological advancements are anticipated to boost market growth over the forecast period. Extensive research & development activities by major companies and universities across the globe for developments in breast implant technology with an aim to increase safety and precision are expected to contribute to market expansion. In June 2019, GC Aesthetics announced the launch of Eve 4.0, a digital consultation solution that provides visualization aids to patients considering breast augmentation.
Some of the prominent players in the breast implants market include Allergan, Mentor Worldwide LLC, Hans biomed, Establishment Labs, Polytech Health & Aesthetics, Sientra, Inc., GC Aesthetics, Cereplas, Groupe Sebbin SAS, and Laboratories Arion, among others.
Download PDF for Deep Analysis on COVID-19’s Impact on “Breast Implant Market” @
The global market is driven by an increase in the number of breast surgeries. A high number of surgeries are performed in the U.S., Brazil, and Mexico. According to the International Society of Aesthetic Plastic Surgery, 1.8 million breast augmentation surgeries were performed in 2018 out of which, 88% of total 2018 breast implants were silicone; 12% were saline. An increase in the number of surgeries is also propelling the demand for breast implants. This, in turn, aids substantial growth in the breast implant market.
The market is also driven by new product launches and technological advancements. Most players are involved in the manufacture of various types of breast implants, offering maximum advantages. For Instance, In Jan 2017 Allergan Plc. received FDA’s approval to market NATRELLE INSPIRA SoftTouch breast implants in the US. Additionally in Jan 2018 Sientra Inc., received FDA approval of the PMA supplement, allowing commercialization of its OPUS-branded breast implant products manufactured by Vesta. This is expected to propel growth of the overall breast implant market.
Get Interesting Discount @
Segmentation Based On:
By Product –
Silicone Breast Implants
Saline Breast Implants
By Application –
Table of Contents
- Market Definition
- Market Classification
- Geographic Scope
- Years Considered for the Study: Historical Years – 2016 & 2017; Base Year – 2018; Forecast Years – 2019 to 2030
- Currency Used
- RESEARCH METHODOLOGY
- Research Framework
- Data Collection Technique
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Methodology
- Bottom Up Approach
- Top Down Approach
- Data Validation and Triangulation
- Market Forecast Model
- Limitations/Assumptions of the Study
- ABSTRACT OF THE STUDY
- MARKET DYNAMICS ASSESSMENT
- UNIQUE SELLING PROPOSITIONS (USPs)
- Epidemiological Assessment: Chronic Respiratory Diseases
- Key Product Assessment
Have any query? Inquiry here for Customization about report at:
About Market Industry Reports
Market Industry Reports is at the forefront of innovation to address the worldwide industry trends and opportunities. We identified the caliber of market dynamics & hence we excel in the areas of innovation and optimization, integrity, curiosity, customer and brand experience, and strategic business intelligence through our research.
Phone: +1 347 767 5477 ( US ) + 91 8956 767 535 ( IN ) + 44 131 463 4161 ( UK )